Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors

NCT02283489 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Head and Neck Neoplasms

Interventions

DRUG: recombinant human endostatin adenovirus
DRUG: Cisplatin injection
DRUG: Paclitaxel injection

Sponsor

Renmiao Zhang

Collaborators

[object Object]